Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells

Area of Science:

• Immunology
• Cancer Biology
• Cellular Metabolism

Background:

• Cancer immune evasion is a major hurdle for effective immunotherapy.
• Understanding novel immune evasion mechanisms is crucial for developing advanced cancer treatments.

Purpose of the Study:

• To investigate the role of mitochondria transfer between immune cells and cancer cells.
• To explore nanotube-mediated mitochondrial hijacking as a cancer immune evasion strategy.
• To evaluate therapeutic strategies targeting this mechanism.

Main Methods:

• Field-emission scanning electron microscopy to visualize nanotubes.
• Fluorophore-tagged mitochondrial transfer tracing.
• Metabolic quantification to assess cellular energy levels.
• Pharmacological inhibition of nanotube formation and immune checkpoint blockade.

Main Results:

• Cancer cells acquire mitochondria from immune cells via nanotubes, enhancing their metabolism.
• Immune cells experience mitochondrial depletion, impairing their function.
• Inhibition of nanotube formation reduced mitochondrial transfer and preserved immune cell function.
• Combined therapy (nanotube inhibitor + PD-1 inhibitor) demonstrated improved anti-tumour effects.

Conclusions:

• Nanotube-mediated mitochondrial transfer is a novel mechanism of cancer immune evasion.
• Targeting mitochondrial hijacking offers a new avenue for cancer immunotherapy.
• Combined therapeutic approaches show promise for aggressive breast cancer treatment.